Reduction of myocardial infarct size in rabbits by ramiprilat: reversal by the bradykinin antagonist HOE 140.
about
The kallikrein-kinin system in diabetic nephropathyRole of cardiac renin angiotensin system in ischemia reperfusion injury and preconditioning of heartApstatin, a selective inhibitor of aminopeptidase P, reduces myocardial infarct size by a kinin-dependent pathwayRole of bradykinin and eNOS in the anti-ischaemic effect of trandolaprilPartial hindlimb occlusion reduced the susceptibility to sustained ventricular tachycardia in conscious rats.Tonic stimulation of renin gene expression by nitric oxide is counteracted by tonic inhibition through angiotensin IIAssessment of the role of the renin-angiotensin system in cardiac contractility utilizing the renin inhibitor remikirenRole of bradykinin receptors in the renal effects of inhibition of angiotensin converting enzyme and endopeptidases 24.11 and 24.15 in conscious rabbits.The kallikrein-kinin system as a regulator of cardiovascular and renal function.Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors.Diverse factors influencing angiotensin metabolism during ACE inhibition: insights from molecular biology and genetic studies.Enhanced reduction of myocardial infarct size by combined ACE inhibition and AT(1)-receptor antagonism.Bradykinin inhibits development of myocardial infarction through B2 receptor signalling by increment of regional blood flow around the ischaemic lesions in ratsEffect of enalaprilat on bradykinin and des-Arg9-bradykinin release following reperfusion of the ischaemic rat heart.
P2860
Q26827473-A6635171-13B6-4E59-9DB0-3E1C1B6915F9Q28079603-9511544B-BD7F-4A16-83A2-87D0424785A3Q28359004-CF7C5DAD-2C0E-46D3-8D0E-386666AF844DQ28363838-90B4E477-E97A-4080-A466-407EFC075DCBQ33498729-EE41A30C-ABD8-42F4-BAC5-5376623A5C2AQ34023281-288534E6-471C-43FC-BBC3-D0F7508CD19EQ35873446-4F028B64-4E0A-4D33-84BB-D7E2E88EBE8AQ35884635-576ED13C-462E-459C-819A-D5E2D7F82581Q36389061-39DFDE6C-A57E-46F4-BCBF-9AA3FDCBE1F2Q37365932-CDB66241-1EB0-4FD0-8115-5B0B4D61AF73Q41894719-E76B5C8D-4306-40C4-A5B1-8DE064A68AACQ42224915-899C61BF-8D48-49C9-8A07-A88F11BA07B4Q42595703-1D2402DB-A5AD-4CCE-9142-3B9B6CDC2AB3Q42712204-7B1781F3-A313-402B-8DF7-25A0DBAA70CE
P2860
Reduction of myocardial infarct size in rabbits by ramiprilat: reversal by the bradykinin antagonist HOE 140.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh-hant
name
Reduction of myocardial infarc ...... bradykinin antagonist HOE 140.
@en
Reduction of myocardial infarc ...... bradykinin antagonist HOE 140.
@nl
type
label
Reduction of myocardial infarc ...... bradykinin antagonist HOE 140.
@en
Reduction of myocardial infarc ...... bradykinin antagonist HOE 140.
@nl
prefLabel
Reduction of myocardial infarc ...... bradykinin antagonist HOE 140.
@en
Reduction of myocardial infarc ...... bradykinin antagonist HOE 140.
@nl
P2093
P1476
Reduction of myocardial infarc ...... bradykinin antagonist HOE 140
@en
P2093
J C Hartman
R J Shebuski
T G Hullinger
P304
P356
10.1097/00005344-199306000-00022
P407
P577
1993-06-01T00:00:00Z